Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.

Do analysts prefer HBIO or TMO?

Harvard Bioscience presently has a consensus target price of $4.50, indicating a potential upside of 1,174.79%. Thermo Fisher Scientific has a consensus target price of $607.43, indicating a potential upside of 41.75%. Given Harvard Bioscience's higher possible upside, analysts clearly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.81

Which has better valuation & earnings, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$94.14M	0.17	-$3.41M	-$0.29	-1.22
Thermo Fisher Scientific	$42.90B	3.77	$6.34B	$17.05	25.13

Which has more risk & volatility, HBIO or TMO?

Harvard Bioscience has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 14.78% compared to Harvard Bioscience's net margin of -14.57%. Thermo Fisher Scientific's return on equity of 17.51% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-14.57%	-4.64%	-2.40%
Thermo Fisher Scientific	14.78%	17.51%	8.52%

Does the media refer more to HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 45 more articles in the media than Harvard Bioscience. MarketBeat recorded 59 mentions for Thermo Fisher Scientific and 14 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 0.68 beat Harvard Bioscience's score of -0.30 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Harvard Bioscience	0 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	4 Negative mention(s)	3 Very Negative mention(s)	Neutral
Thermo Fisher Scientific	32 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in HBIO or TMO?

Thermo Fisher Scientific received 722 more outperform votes than Harvard Bioscience when rated by MarketBeat users. Likewise, 80.70% of users gave Thermo Fisher Scientific an outperform vote while only 71.51% of users gave Harvard Bioscience an outperform vote.

Company	Underperform	Outperform
Harvard Bioscience	Outperform Votes 369 71.51%	Underperform Votes 147 28.49%
Thermo Fisher Scientific	Outperform Votes 1091 80.70%	Underperform Votes 261 19.30%

Do insiders & institutionals have more ownership in HBIO or TMO?

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.0% of Harvard Bioscience shares are owned by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 15 of the 18 factors compared between the two stocks.